Intercontinental Exchange GC sells 4,573 shares
Intercontinental Exchange General Counsel Andrew J. Surdykowski reported an exercise-and-sell transaction in company stock.
Rhea-AI Filing Summary
Intercontinental Exchange General Counsel Andrew J. Surdykowski reported an exercise-and-sell transaction in company stock. On May 26, 2026, he exercised employee stock options to acquire 2,065 shares of common stock at $57.31 per share, then sold a total of 4,573 shares in open-market transactions around $151 per share pursuant to a pre-established Rule 10b5-1 trading plan. After these transactions, he directly holds 45,473 shares of common stock, alongside remaining fully vested options and equity awards including restricted stock units and performance-based units that vest over multi-year periods.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
4 txns
Insider
Surdykowski Andrew J
Role
General Counsel
Sold
4,573 shs ($693K)
Approx. gross sale proceeds
$693K
Approx. exercise cost
$118K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) Holding | 2,065 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,065 | $57.31 | $118K |
| Sale | Common Stock | 1,965 | $150.9729 | $297K |
| Sale | Common Stock | 2,608 | $151.9981 | $396K |
Holdings After Transaction:
Employee Stock Option (right to buy) Holding — 4,129 contracts (Direct);
Common Stock — 45,473 shares (Direct)
Footnotes (7)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.
- F2. The price range for the aggregate amount sold by the direct holder is $150.46 - $151.45. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- F3. The price range for the aggregate amount sold by the direct holder is $151.95 - $152.00. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
- F4. The common stock number referred in Table I is an aggregate number and represents 38,299 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
- F5. The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
- F6. The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
- F7. These options are fully vested.
Key Figures
Shares sold: 4,573 shares
Sale prices: $151.9981 and $150.9729 per share
Options exercised: 2,065 shares at $57.31/share
+5 more
8 metrics
Shares sold
4,573 shares
Common stock sold in open-market transactions on May 26, 2026
Sale prices
$151.9981 and $150.9729 per share
Average prices for 2,608 and 1,965 ICE shares sold
Options exercised
2,065 shares at $57.31/share
Employee stock option exercise into ICE common stock
Shares held after
45,473 shares
Direct ICE common stock holdings following transactions
Options remaining
4,129 options
Employee stock options outstanding after exercise, expiring January 18, 2027
Equity award components
38,299 shares, 5,734 RSUs, 1,440 PSUs
Breakdown of aggregate common stock number in Table I
Trading plan effective date
November 25, 2025
Rule 10b5-1 plan governing reported stock sales
Option expiration
January 18, 2027
Expiration date for the option grant exercised and remaining
Key Terms
Rule 10b5-1 trading plan, restricted stock units ("RSUs"), performance based restricted stock units ("PSUs"), TSR PSUs, +2 more
6 terms
Rule 10b5-1 trading plan regulatory
"This transaction was effected pursuant to a Rule 10b5-1 trading plan..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
restricted stock units ("RSUs") financial
"represents 38,299 shares of common stock and 5,734 unvested restricted stock units ("RSUs")..."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
performance based restricted stock units ("PSUs") financial
"and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied."
TSR PSUs financial
"The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares..."
EBITDA PSUs financial
"The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs..."
Deal Incentive Awards financial
"performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares..."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did ICE General Counsel Andrew Surdykowski report?
He reported an option exercise and related stock sales. On May 26, 2026, he exercised options for 2,065 ICE shares at $57.31 and sold 4,573 common shares in open-market trades executed under a Rule 10b5-1 trading plan.
What options did ICE’s General Counsel exercise in this Form 4 filing?
He exercised employee stock options for 2,065 shares. The options had a conversion or exercise price of $57.31 per share, related to common stock, and are described as fully vested, with an option grant expiring on January 18, 2027.
Was the ICE General Counsel’s stock sale pre-planned under a Rule 10b5-1 plan?
Yes, the sales were executed under a Rule 10b5-1 trading plan. A footnote states the plan was approved and became effective as of November 25, 2025, indicating the transactions were pre-arranged rather than opportunistic discretionary trades.
What long-term equity awards does the ICE General Counsel have outstanding?
He holds RSUs and several types of PSUs with future vesting dates. Footnotes describe TSR PSUs and EBITDA PSUs with outcomes determined in February 2027–2029, and Deal Incentive Award PSUs with performance measurement through December 2026–2028 plus further time-based vesting and holding requirements.
AI-generated analysis. How Rhea-AI works. Not financial advice.
